JIM CRAMERNike, Beyond Meat, Mastercard: 'Mad Money' Lightning RoundBy Scott RuttNov 8, 2019 8:34 PM EST
JIM CRAMERSymantec, Clorox, United Rentals: 'Mad Money' Lightning RoundBy Scott RuttJul 16, 2019 11:56 PM EDT
JIM CRAMERWhen a Good Stock Goes Down: Cramer's 'Mad Money' RecapBy Scott RuttJul 16, 2019 11:53 PM EDT
INVESTINGIllumina Plunges on Lower Second-Quarter GuidanceBy M. Corey GoldmanJul 12, 2019 9:57 AM EDT
STOCKSAs 'Precision Medicine' Starts to Take Off, Here's Who's Poised to CapitalizeBy Jon MarkmanJul 7, 2019 9:00 AM EDT
STOCKSPacific Bio shares fall on U.K. antitrust concern about Illumina dealBy Rob DanielJun 18, 2019 10:09 AM EDT
JIM CRAMERYeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning RoundBy Bret KenwellFeb 11, 2019 8:22 PM EST
INVESTINGHealth Care Is About to Improve Dramatically; Here's How to Play itBy Jon MarkmanFeb 10, 2019 9:00 AM EST
STOCKSGene Editing Offers Promise of Personalized Health Care -- Here's How to Play ItBy Jon MarkmanDec 7, 2018 8:30 AM EST
OPINIONZuora's CEO Tells TheStreet Why He Still Sees a Lot of Room to GrowBy Eric JhonsaAug 31, 2018 2:41 PM EDT
JIM CRAMERBiotech's Coming Back to Life: Cramer's 'Off the Charts'By Tom BemisJul 18, 2018 6:59 AM EDT
JIM CRAMERMarket Refuses To Go Lower: Cramer's 'Mad Money' RecapBy Scott RuttJul 18, 2018 6:26 AM EDT
STOCKS16 Amazing Stocks to Trade in This Unstoppable Bull MarketBy Kinsey GrantNov 28, 2017 11:49 AM EST
FUTURESDow Finishes Above 22,000 and Posts Sixth Straight Record as Apple Reaches New HeightsBy Keris Alison LahiffAug 2, 2017 8:00 PM EDT
FUTURESApple Gains Put Dow on Track for Sixth Straight Record CloseBy Keris Alison LahiffAug 2, 2017 3:05 PM EDT
HOW-TOWill Illumina Maintain This Feverish Pace? Chart Shows What's NextBy Gary MorrowAug 2, 2017 12:17 PM EDT
HEALTHIllumina Shares Jump on Better-Than-Expected Second-Quarter NumbersBy Armie Margaret LeeAug 2, 2017 11:17 AM EDT
